Showing results (361-370 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|March 22, 2018
Engaging Anaphase Catastrophe Mechanisms to Eradicate Aneuploid CancersMasanori Kawakami, Lisa Maria Mustachio, Xi Liu, et al.
Molecular Cancer Therapeutics|December 8, 2018
KDM5B Promotes Drug Resistance by Regulating Melanoma-Propagating Cell SubpopulationsXiaoni Liu, Shang-Min Zhang, Meaghan K McGeary, et al.
Molecular Cancer Therapeutics|December 8, 2018
Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer PatientsTaylor J Jensen, Aaron M Goodman, Shumei Kato, et al.
Molecular Cancer Therapeutics|December 28, 2018
TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell-Mediated Regression of Pancreatic CancerDaniel R Principe, Alex Park, Matthew J Dorman, et al.
Molecular Cancer Therapeutics|December 28, 2018
TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade In Vitro and In VivoSrimoyee Ghosh, Geeta Sharma, Jon Travers, et al.
Molecular Cancer Therapeutics|November 28, 2018
Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to RadiotherapyErika Zernickel, Ali Sak, Assad Riaz, et al.
Molecular Cancer Therapeutics|December 1, 2019
Anticancer Activity of ZnO Nanoparticles against Human Small-Cell Lung Cancer in an Orthotopic Mouse ModelRyosuke Tanino, Yoshihiro Amano, Xuexia Tong, et al.
Molecular Cancer Therapeutics|December 15, 2017
Phase I Dose-Escalation Study of Anti-CTLA-4 Antibody Ipilimumab and Lenalidomide in Patients with Advanced CancersDivya Sakamuri, Isabella C Glitza, Sonia L Betancourt Cuellar, et al.
Molecular Cancer Therapeutics|December 15, 2017
Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine CancerYan Huang, Wei Hu, Jie Huang, et al.
Molecular Cancer Therapeutics|November 17, 2017
CAT-02-106, a Site-Specifically Conjugated Anti-CD22 Antibody Bearing an MDR1-Resistant Maytansine Payload Yields Excellent Efficacy and Safety in Preclinical ModelsPenelope M Drake, Adam Carlson, Jesse M McFarland, et al.
Pageof 599